These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16143788)

  • 1. Quality assurance: fundamental reproducibility tests for 3-D treatment-planning systems.
    Able CM; Thomas MD
    J Appl Clin Med Phys; 2005; 6(3):13-22. PubMed ID: 16143788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commissioning and quality assurance of a commercial stereotactic treatment-planning system for extracranial IMRT.
    Wang L; Li J; Paskalev K; Hoban P; Luo W; Chen L; McNeeley S; Price R; Ma C
    J Appl Clin Med Phys; 2006; 7(1):21-34. PubMed ID: 16518314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMRT quality assurance using a second treatment planning system.
    Anjum MN; Parker W; Ruo R; Aldahlawi I; Afzal M
    Med Dosim; 2010; 35(4):274-9. PubMed ID: 19944590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric verification of radiotherapy treatment planning systems in Serbia: national audit.
    Rutonjski L; Petrović B; Baucal M; Teodorović M; Cudić O; Gershkevitsh E; Izewska J
    Radiat Oncol; 2012 Sep; 7():155. PubMed ID: 22971539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning.
    Fraass B; Doppke K; Hunt M; Kutcher G; Starkschall G; Stern R; Van Dyke J
    Med Phys; 1998 Oct; 25(10):1773-829. PubMed ID: 9800687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commissioning and implementation of a stereotactic conformal radiotherapy technique using a general-purpose planning system.
    Mosleh-Shirazi MA; Hansen VN; Childs PJ; Warrington AP; Saran FH
    J Appl Clin Med Phys; 2004; 5(3):1-14. PubMed ID: 15753935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An IMRT dose distribution study using commercial verification software.
    Liu G; Fernando W; Grace M; Rykers K
    Australas Phys Eng Sci Med; 2004 Sep; 27(3):129-35. PubMed ID: 15580842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commissioning and comprehensive quality assurance of commercial 3D treatment planning system using IAEA Technical Report Series-430.
    Jamema SV; Upreti RR; Sharma S; Deshpande DD
    Australas Phys Eng Sci Med; 2008 Sep; 31(3):207-15. PubMed ID: 18946979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards an objective evaluation of tolerances for beam modeling in a treatment planning system.
    Rangel A; Ploquin N; Kay I; Dunscombe P
    Phys Med Biol; 2007 Oct; 52(19):6011-25. PubMed ID: 17881816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced dynamic wedge and independent monitor unit verification.
    Howlett SJ
    Australas Phys Eng Sci Med; 2005 Mar; 28(1):26-36. PubMed ID: 15920987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study to establish reasonable action limits for patient-specific quality assurance in intensity-modulated radiation therapy.
    Both S; Alecu IM; Stan AR; Alecu M; Ciura A; Hansen JM; Alecu R
    J Appl Clin Med Phys; 2007 Mar; 8(2):1-8. PubMed ID: 17592459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commissioning and quality assurance for intensity modulated radiotherapy with dynamic multileaf collimator: experience of the Pontificia Universidad Católica de Chile.
    Venencia CD; Besa P
    J Appl Clin Med Phys; 2004; 5(3):37-54. PubMed ID: 15753938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planning quality and delivery efficiency of sMLC delivered IMRT treatment of oropharyngeal cancers evaluated by RTOG H-0022 dosimetric criteria.
    Zhu XR; Schultz CJ; Gillin MT
    J Appl Clin Med Phys; 2004; 5(4):80-95. PubMed ID: 15738923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose delivery verification method for conventional and intensity-modulated radiation therapy using measured field fluence distributions.
    Renner WD; Sarfaraz M; Earl MA; Yu CX
    Med Phys; 2003 Nov; 30(11):2996-3005. PubMed ID: 14655947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It is necessary to validate each individual IMRT treatment plan before delivery. For the proposition.
    Ramsey C
    Med Phys; 2003 Sep; 30(9):2271-2. PubMed ID: 14528945
    [No Abstract]   [Full Text] [Related]  

  • 16. Dosimetric evaluation of the clinical implementation of the first commercial IMRT Monte Carlo treatment planning system at 6 MV.
    Heath E; Seuntjens J; Sheikh-Bagheri D
    Med Phys; 2004 Oct; 31(10):2771-9. PubMed ID: 15543782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance for 3D conformal radiation therapy.
    Purdy JA; Harms WB
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():2-7. PubMed ID: 9810330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quality assurance phantom for IMRT dose verification.
    Ma CM; Jiang SB; Pawlicki T; Chen Y; Li JS; Deng J; Boyer AL
    Phys Med Biol; 2003 Mar; 48(5):561-72. PubMed ID: 12696795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
    Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
    Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It is necessary to validate each individual IMRT treatment plan before delivery. Against the proposition.
    Dube S
    Med Phys; 2003 Sep; 30(9):2272-3. PubMed ID: 14528946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.